NasdaqCM:CMPXBiotechs
Will Compass Therapeutics’ (CMPX) New Oncology Leaders Redefine Its Path From Pipeline to Commercial Scale?
Compass Therapeutics has appointed Arjun Prasad as Chief Commercial Officer and Cynthia Sirard as Chief Medical Officer, with both roles effective January 1, 2026, adding experienced oncology leadership across commercial and clinical development functions.
These hires bring deep experience in successful oncology drug launches and advancing immuno-oncology programs through pivotal trials and regulatory approvals, potentially strengthening Compass Therapeutics’ execution capabilities.
Next,...